Benzinga · Jun 11, 2026
GN
NASDAQ · GNTA
Genenta Science S.p.A.
Healthcare · Biotechnology
$0.84
Down-$0.02 (-2.38%)
Updated Sep 12, 2026, 3:34 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 31.78M
- P/E ratio
- -3.05
- Dividend yield
- 0.00%
- 52-week range
- $0.55 – $2.58
- Volume
- 32.9K
- Avg. volume
- 666.12K
Price performance
GNTA price history
1M range · 0 trading sessions · Daily adjusted prices
GNTA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest GNTA news
The latest Smart Investors Daily articles mentioning GNTA.
Stock researchCompany · Overview
GNTA research
Overview
Company profile and research snapshot.
Company profile
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 2, 2024 | HC Wainwright & Co. | Buy | — |
| May 13, 2024 | HC Wainwright & Co. | Buy | — |
| Feb 8, 2023 | HC Wainwright & Co. | Buy | — |
| Jan 5, 2023 | EF Hutton | Buy | — |
| Jul 25, 2022 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Apr 23, 2026
Genenta Science Signs Definitive Agreements With Sòphia High Tech; Genenta Expects To Fund Total Of €6 Million In Two Tranches
Genenta Science S.p.A. (NASDAQ:GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that it
Finnhub · Apr 23, 2026
Genenta signs Definitive Agreements with Sophia High Tech
Genenta enters aerospace as it continues its strategic transformation into a next-generation industrial consolidatorMILAN,Italy, April 23, 2026 -- Genenta Science S.p.A. , evolving into Saentra...
Benzinga · Mar 27, 2026
Genenta Science Enters Into Binding Offer With Sòphia High Tech For €6M Through Two Reserved Capital Increases, With The Goal Of Reaching Controlling Stake Upon The Achievement Of Defined Performance Milestones
Genenta Science S.p.A. (NASDAQ:GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that it
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
